Health
Comparative performance of five commercially available serologic assays to detect antibodies to SARS-CoV-2 and identify individuals with high neutralizing titers – DocWire News
medRxiv. 2020 Sep 2:2020.08.31.20184788. doi: 10.1101/2020.08.31.20184788. Preprint.ABSTRACTAccurate serological assays to detect antibodies to SARS-CoV-2
medRxiv. 2020 Sep 2:2020.08.31.20184788. doi: 10.1101/2020.08.31.20184788. Preprint.
ABSTRACT
Accurate serological assays to detect antibodies to SARS-CoV-2 are needed to characterize the epidemiology of SARS-CoV-2 infection and identify potential candidates for COVID-19 convalescent plasma (CCP) donation. This study compared the performance of commercial enzyme immunoassays (EIAs) to detect IgG or total antibodies to SARS-CoV-2 and neutralizing antibodies (nAb). The diagnostic accuracy of fiv…
-
Business21 hours agoForget CBA and buy these high-yield ASX dividend shares
-
Business24 hours ago5 easy steps to build a $100,000 ASX share portfolio
-
Noosa News23 hours ago“There’s No Going Back”: The Grid Meets the Real World in the Initial Trailer for Third ‘TRON’ Movie ‘Ares’
-
Business22 hours agoTop brokers name 3 ASX shares to buy next week 6 April 2025